• Dyslipidemia Treatment And CVD Risk In Adult Russians Who Reported Dyslipidemia

    Oct 1, 2017, 00:00

  • Drug Utilization in a Cardiology Unit of a Referral Hospital in Nigeria

    Oct 1, 2017, 00:00

  • Primary Prevention of Hyperlipidemia- Treatment and Compliance in Real World Practice

    Oct 1, 2017, 00:00

  • Budget Impact Model of Secukinumab for Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis Treatment in Italy

    Oct 1, 2017, 00:00

  • Cost-Effectivenes Analysis of Anti-Tnf Use Compared To Dmards in The Fatal and Nonfatal Acute Coronary Ischemic Event

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Treatments For Hepatitis C Virus- What’s New?

    Oct 1, 2017, 00:00

  • The Research And Suggestions On The Accessibility Of High Value Drugs In China

    Oct 1, 2017, 00:00

  • Burden of Disease on Chronic Heart Failure Patients- A Multinational Cross-Sectional Survey in Real World Setting

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Haploidentical Vs Matched Unrelated Allogeneic Hematopoietic Stem Cells Transplantation in Patients Older Than 55 Years

    Oct 1, 2017, 00:00

  • The Prevalence and Treatment Status of Different Multiple Sclerosis Phenotypes in a Italian Reference Center

    Oct 1, 2017, 00:00

  • Statistical Trend Analysis of German Benefit Ratings And Their Correlation With Negotiated Rebates Focusing on Orphan Oncologics

    Oct 1, 2017, 00:00

  • The Comparative Cost-Effectiveness of Cabozantinib, Everolimus and Axitinib in Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy- Scottish Perspective

    Oct 1, 2017, 00:00

  • Patterns In Working Days Lost By Parents Of Children Newly-Diagnosed With Type 1 Diabetes (T1D)

    Oct 1, 2017, 00:00

  • Validation of Surrogate Endpoints In Melanoma Therapies and Use In HTA

    Oct 1, 2017, 00:00

  • Do People With Private Health Insurance Attach A Higher Value To Health Than Those Without Insurance? Results From An EQ-5D-5L Valuation Study In The Republic Of Ireland

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino EN EL Sector Público De Argentina

    Oct 1, 2017, 00:00

  • Time Restricted Decisions In German Benefit Assessments – A Success Story?

    Oct 1, 2017, 00:00

  • Cost of Type 2 Diabetes Management And Associated Complications In Spain

    Oct 1, 2017, 00:00

  • FOLLOW-UP OF PEDIATRIC PATIENTS UNDER TREATMENT WITH SOMATROPIN IN BRAZIL THROUGH A PATIENT SUPPORT PROGRAM (PSP)

    Oct 1, 2017, 00:00

  • Developing A Conceptual Modelling Framework For Economic Evaluation

    Oct 1, 2017, 00:00

  • Intestinal Parasitic Disease And Hygienic Conditions In Children- Diagnostic Evaluation For Prevention

    Oct 1, 2017, 00:00

  • Development of A New Patient-Reported Outcome Instrument To Evaluate Treatments For Stretchmarks- The Body-Q Stretchmark Scale

    Oct 1, 2017, 00:00

  • Preoperative Smoking Cessation- Recording of Smoking Status in the Porvoo Hospital Area in Finland

    Oct 1, 2017, 00:00

  • Real-World Evidence of Direct-Acting Antivirals Persistence on Planned Hepatitis C Treatment

    Oct 1, 2017, 00:00

  • Structured Education Program For Injection Technique - Budget Impact Model

    Oct 1, 2017, 00:00

  • Centralized Procurement of Medical Devices In Italy- A Methodology Towards Standardized Tender Dossier

    Oct 1, 2017, 00:00

  • Risk-Stratified Breast Cancer Screening and Non-Adherence in Germany

    Oct 1, 2017, 00:00

  • The Multicriteria Decision Analysis Of Using Tetrabenazine For Patients With Hungtington’s Disease In Russia

    Oct 1, 2017, 00:00

  • Estudio De Costo-Efectividad E Impacto Presupuestal De Denosumab vs. Ácido Zoledrónico Para El Manejo De Metástasis Óseas En Pacientes Con Cáncer De Próstata En Colombia

    Oct 1, 2017, 00:00

  • Access and Secondary Use of Data Collected In An Electronic Medical Chart- Results Of The Real World Roswitch Study

    Oct 1, 2017, 00:00

  • Skin-Based Temperature Measuring With Different Thermometer Types

    Oct 1, 2017, 00:00

  • Cost Consequence Analysis Of Different Gene Mutation Testing Modalities For Braf V600E Mutation In Advanced Non-Small Cell Lung Cancer Using A Decision Analytic Model

    Oct 1, 2017, 00:00

  • A Systematic Literature Review Of The Societal Costs And Consequences Of Heroin Addiction

    Oct 1, 2017, 00:00

  • The Use of Mcda In HTA Decision Making In Bulgaria

    Oct 1, 2017, 00:00

  • Effect Of Hesperidin In Bleomycin-Induced Pulmonary Fibrosis In Rats- Critical Role Of NRF-2, TNF-Α, AND IL-1Β

    Oct 1, 2017, 00:00

  • A Model For Alzheimer’s Disease In The Prevention Setting

    Oct 1, 2017, 00:00

  • Comparing Costs and Outcomes Between Coblation Technology And Mechanical Debridement In The Treatment of Knee Cartilage Lesions- A Cost-Effectiveness Analysis From A Us Payer Perspective

    Oct 1, 2017, 00:00

  • Community Pharmacists' Interest In And Attitude To Pharmacy Practice Research In Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Costs of Clinical Events in Diabetes Type 2 Patients in the Netherlands- A Systematic Review

    Oct 1, 2017, 00:00

  • Patient Characteristics And Bleeding Events In Non-Valvular Atrial Fibrillation Patients Treated With Apixaban or Vitamin K Antagonists- Real-World Evidence From Italian Administrative Databases

    Oct 1, 2017, 00:00

  • Socio-Ecological Contextual Factors Associated with Hypertension Medication and Control Among the Elderly in Three Middle-Income Countries (Albania, Brazil, and Colombia)

    Oct 1, 2017, 00:00

  • The Influence Of Pharmaceutical Reform In Korea A Decade Ago- What We Walked

    Oct 1, 2017, 00:00

  • Systematic Review of Herpes Zoster Epidemiology- Available Evidence In Spain Related To Specific Sub-Populations

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Moderate-to-Severe Plaque Psoriasis Patients in Brazil

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Duragraft As A Vein Graft Treatment In Coronary Artery Bypass Grafting In Turkey

    Oct 1, 2017, 00:00

  • Application of Mixed-Method Study Designs in Health- Economic- Related Studies. A Narrative Review

    Oct 1, 2017, 00:00

  • A Comparison Of Systemic Pediatric Fluoroquinolone Use In South Korea

    Oct 1, 2017, 00:00

  • Understanding Health Technology Assessment Outcomes For Products With Conditional Market Authorisation In Fran Initial Evaluation VS. Re-Assessment

    Oct 1, 2017, 00:00

  • A Modified Time Trade-Off Experiment In EQ-5D-3L Valuation With Fuzzy Health States Utilities

    Oct 1, 2017, 00:00

  • Celebrity Deathmatch- Burden Of Disease VS RCTS In The Southern Cone Of Latin America

    Oct 1, 2017, 00:00

  • A UNIFORM PROBABILISTIC APPROACH TO MANAGE UNCERTAINTIES REGARDING VACCINE EFFECTIVENESS AGAINST SEROTYPE 3, 19A, NTHI AND HERD EFFECT IN THE BASE CASE OF A COST-EFFECTIVENESS ANALYSIS COMPARING NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D ...

    Oct 1, 2017, 00:00

  • The Effect of Perceived Financial Burden of Prescription Co-Payments on Medication Adherence

    Oct 1, 2017, 00:00

  • Enhancement Program For Couples Adjustment To Failed Assisted Reproductive Technology

    Oct 1, 2017, 00:00

  • External Reference Pricing In Greece. A Comparative Analysis For 2015-2017

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey

    Oct 1, 2017, 00:00

  • The Introduction Of A Threshold For The Icer And The Implications For Reimbursement Of Drugs In The Dutch Healthcare System

    Oct 1, 2017, 00:00

  • Burden of Genital Warts In Ecuador- An Observational Study

    Oct 1, 2017, 00:00

  • Desarrollo De Material Audiovisual Educativo Basado En La Evidencia Para Promover La Salud Materna Y Neonatal

    Oct 1, 2017, 00:00

  • Implementation of Nice Guidance for the Treatment of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Effectiveness Of Lacosamide For The Treatment Of Non-Controlled Focal Epilepsy

    Oct 1, 2017, 00:00

  • Disease-Related Cost Burden In Patients Undergoing Sinus Surgery For Chronic Rhinosinusitis- A Claims-Based Analysis

    Oct 1, 2017, 00:00

  • Knowledge And Satisfaction Of Health Insurance Clients- Cross-Sectional Study Of A Tertiary Hospital Services In Ghana

    Oct 1, 2017, 00:00

  • Barriers to the Introduction of Actual Technologies for Induction of Labor Management

    Oct 1, 2017, 00:00

  • Developing New Practice Model To Ensure Better Medication Concordance

    Oct 1, 2017, 00:00

  • Palliative Care Services In Romania- Analysis Of Utilization, Funding And Coverage

    Oct 1, 2017, 00:00

  • Varicella-Related Hospitalizations- Brazilian Retrospective Analysis After The Inclusion of A Vaccine in The National Immunization Program

    Oct 1, 2017, 00:00

  • Feasibility Of Precision Oncology Virtual Tumor Boards To Optimize Direct Point-Of-Care Management And Clinical Trial Enrollment Of Advanced Cancer Patients

    Oct 1, 2017, 00:00

  • Closing The Evidence Gap For Orphan Drugs- Do German Regulatory Requirements Give Incentives For High Level Evidence Generation?

    Oct 1, 2017, 00:00

  • Burden of Disease for Psoriasis In Argentina, Brazil, Colombia and Mexico

    Oct 1, 2017, 00:00

  • Inclusion of Comparator Single Arm Trials Used for Ema/Fda Registration In The Network Meta-Analysis Using Matching Adjusted Indirect Comparisons

    Oct 1, 2017, 00:00

  • Development of A Patient-Reported Questionnaire In Patients With Chronic Pruritus

    Oct 1, 2017, 00:00

  • The UK's Binge Drinking Culture- Losing More Than Just Our Dignity?

    Oct 1, 2017, 00:00

  • Adherence Issues in Multiple Sclerosis Treatment- How Can Acceptance Measurement Help Understanding Patients’ Concerns and Working on Solutions?

    Oct 1, 2017, 00:00

  • Anticonvulsant Drugs Use Evaluation Survey Among Ambulatory Epileptic Patients In A Tertiary Teaching Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Disease Burden Of Fractures In Patients With Osteoporosis In Japan

    Oct 1, 2017, 00:00

  • Evaluation And Development of Habitual Posture And Posture Deemed Correct With Back School Program Among Primary School Children

    Oct 1, 2017, 00:00

  • Disclosing Traditional CM) Use to the Health Care Providers- A Qualitative Study Among Thalassemia Patients in Malaysia

    Oct 1, 2017, 00:00

  • Economic Evaluation of Strategies for Opportunistic Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • Possibilities of Domestic Producers of The Republic of Kazakhstan In The Field of Manufacturing Anti-Tuberculosis Medicines

    Oct 1, 2017, 00:00

  • Mapping From The Bdi-Ii To The EQ-5D-5L Questionnaire In Patients With Major Depression Disorder

    Oct 1, 2017, 00:00

  • What Do The Single Technology Appraisals of The Past Tell US About Fast-Tracking The Most Cost-Effective New Technologies In The Future?

    Oct 1, 2017, 00:00

  • Outcomes And Costs Of Treating Hepatitis C With Direct-Acting Antivirals- Results From The German Hepatitis C-Registry

    Oct 1, 2017, 00:00

  • A Cost Effectiveness Analysis of Obinutuzumab In The Management of Chronic Lymphocytic Leukemia In Greece

    Oct 1, 2017, 00:00

  • Combined Use of Isoniazid and Rifapentine in The Treatment of Latent Tuberculosis- A Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients- A Real-World Study In Sweden

    Oct 1, 2017, 00:00

  • Determining The Comparative Value Of Outcome-Based Money-Back Guarantee Scenarios In Non-Small Cell Lung Cancer Using Real-World Data

    Oct 1, 2017, 00:00

  • Determinants Of The Relationship Between Improved Glucose Control And Modeled Health Outcomes In Type 2 Diabetes Simulation Models

    Oct 1, 2017, 00:00

  • Exploring The Association Between Risk Of Bleeding And Comorbid Conditions For Patients With Warfarin Treatment

    Oct 1, 2017, 00:00

  • Assessing Uptake Of Medicine Use Reviews In English Community Pharmacies

    Oct 1, 2017, 00:00

  • Incontinence Control System (Interstim®) for the Fecal Incontinence Treatment at Healthcare Public Sector in Mexico

    Oct 1, 2017, 00:00

  • The Impact of Scottish Medicines Consortium (SMC) Process Changes on Acceptance Rates for New Medicines for End of Life and Very Rare Conditions

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Anaferon® In The Treatment Of Acute Respiratory Infections In Mexico

    Oct 1, 2017, 00:00

  • Blood Pressure Measuring Techniques, Examination of The Blood Pressure Values In Relation With The Operating Principle of The Device

    Oct 1, 2017, 00:00

  • Comparing The Methods Of Incorporating The Health Related Quality Of Life Of Advanced Cancer Patients In Economic Models

    Oct 1, 2017, 00:00

  • Economic Evaluation of Single Inhaler Triple Therapy For Patients With Chronic Obstructive Pulmonary Disease (COPD) Using The Galaxy Model

    Oct 1, 2017, 00:00

  • Spirometry of Lung Function Evaluation in Stone Crushing Workers Quetta, Pakistan

    Oct 1, 2017, 00:00

  • Evaluating The Use of Central Nervous System Stimulants Among Medical and Non-Medical Students

    Oct 1, 2017, 00:00

  • PROS In Oncology HTA Decisions, Do They Matter?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Preoperative MRI In Ductal Carcinoma In Situ of The Breast

    Oct 1, 2017, 00:00

  • Port Catheter Versus Peripherally Inserted Central Catheter For Adjuvant Chemotherapy In Breast Cancer- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Characteristics Of The Dietary Habits Of Cancer Patients And Structure Of Consumption Of Basic Food Products

    Oct 1, 2017, 00:00

  • Cost-Per-Responder of Fixed Combination Calcipotriol + Betamethasone Dipropionate Aerosol Foam Vs Ointment In Patients With Psoriasis Vulgaris In The UK

    Oct 1, 2017, 00:00

  • Impact Of Using External Reference Pricing (ERP) And Health Technology Assessment (HTA) As Part Of Cost-Containment Policies- Comparison Of Prices In Latin America

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Dabrafenib and Trametinib Combination Therapy in The Treatment of Braf V600e-Mutant Advanced Non-Small Cell Lung Cancer in The United States

    Oct 1, 2017, 00:00

  • Venous Thromboembolism Prophylaxis- Risk Assessment Compliance with Respected Patient Risk

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Chile

    Oct 1, 2017, 00:00

  • Distribuição Das Principais Neoplasias Malignas Segundo Sexo E Ano De Diagnóstico, Registro Hospitalar De Câncer, Instituto Do Câncer Do Estado De São Paulo, 2008-2012

    Oct 1, 2017, 00:00

  • Evaluating Robotreviewer for Automated Risk of Bias Assessment in a Systematic Review- A Case Study

    Oct 1, 2017, 00:00

  • Clinical Evaluation of CEA , CA125, CA19-9 and CA72-4 In Gastric Cancer Patients With Adjuvant Chemotherapy

    Oct 1, 2017, 00:00

  • Possible Mistakes During Blood Pressure Measuring- Inappropriate Posture

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Threshold in Brazil Through A League-Table Approach- Systematic Review

    Oct 1, 2017, 00:00

  • Predicting EQ-5D Utility Index Scores for Gastric Cancer Patients in Japan- A Preliminary Model

    Oct 1, 2017, 00:00

  • Methods for Extracting Treatment Patterns for Renal Cell Carcinoma (RCC) from Social Media (SM) Forums Using Natural Language Processing (NLP) and Machine Learning (ML)

    Oct 1, 2017, 00:00

  • Conversion of a French Electronic Medical Record (Emr) Database into the Observational Medical Outcomes Partnership Common Data Model

    Oct 1, 2017, 00:00

  • Appropriate Psoriatic Arthritis Treatment is Delayed for Years- Results From a Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Direct Costs And Healthcare Resource Use Associated With Patients With Hypercholesterolaemia And Established Cardiovascular Disease In Spain

    Oct 1, 2017, 00:00

  • What Time Do We Dine?”- A Cultural Study To Evaluate People’s Views Of Set Meal Times Across Countries

    Oct 1, 2017, 00:00

  • Modelling Cardiovascular Outcomes In Type 2 Diabetes In The ERA Of Cardiovascular Outcomes Trials

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Antihypertensive Dosage Adjustments By A Pharmacist In A Community Setting

    Oct 1, 2017, 00:00

  • Examining Health Care Utilization and Costs Among Atherosclerosis Patients in the US Veteran Health Administration Population

    Oct 1, 2017, 00:00

  • Risk Adjustments In Economic Models - What Is Their Impact On Predicted Rates?

    Oct 1, 2017, 00:00

  • The Health-Related Quality Of Life (HRQOL) Associated With Ostomy Appliances And Features

    Oct 1, 2017, 00:00

  • Assessment of Quality of Health Economic Studies In Non-Alcoholic Fatty Liver Disease

    Oct 1, 2017, 00:00

  • Cost-Minimization Analyses of Biological Therapies in the Treatment of Rheumatoid Arthritis from the Egyptian Healthcare System Perspective

    Oct 1, 2017, 00:00

  • Open Tibial Fractures With Segmental Defects- A U.S. Retrospective Database Analysis Examining 12-Month Post-Operative Patient Outcomes And Costs

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Thresholds- Review of Methods

    Oct 1, 2017, 00:00

  • Estimating The Impact of Strategies For Cervical Cancer Prevention And Control In Indonesia Using Markov Model

    Oct 1, 2017, 00:00

  • TRENDS AND PREDICTIVE FACTORS OF HRQOL IN TRAUMA PATIENTS. - A PROSPECTIVE COHORT STUDY

    Oct 1, 2017, 00:00

  • Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products

    Oct 1, 2017, 00:00

  • Number of Cases Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • Development of The Oiqol-A- A Health-Related Quality of Life Measure For Adults With Osteogenisis Imperfecta

    Oct 1, 2017, 00:00

  • Predictors of Early Discontinuation of Interferon-Free Direct Antiviral Agents in Patients With HCV and Advanced Fibrosis- Results of A Real-Life Cohort

    Oct 1, 2017, 00:00

  • A Systematic Literature Review of Uk Epidemiology of Brca1 And BRCA2-Mutated Locally Advanced or Metastatic Ovarian Cancer

    Oct 1, 2017, 00:00

  • Identification of Generic Cancer Medicines That Have Undergone Momentous Price Rises in The Nhs in England

    Oct 1, 2017, 00:00

  • Analysis of Warfarin Usage and INR Control in Atrial Fibrillation- A Retrospective Study

    Oct 1, 2017, 00:00

  • Access to Orphan Drugs (ODS) in Spain Compared with EU4 Countries- Inequity and Lack of Price Transparency Across Europe

    Oct 1, 2017, 00:00

  • Cost And Operational Efficiency Comparison Of An Integrated VS. A Multi-Step System For Extracorporeal Photopheresis In Germany

    Oct 1, 2017, 00:00

  • Conventional and Biological Therapy in Patients with Rheumatoid Arthritis. A Cost Analysis in Colombia

    Oct 1, 2017, 00:00

  • Development And Evaluation Of Onconurse Practice− A Smartphone Application For Oncology Nurses

    Oct 1, 2017, 00:00

  • Growth Hormone Pharmacoeconomics and Prescription Data for Children Outpatients in a Regional General Hospital

    Oct 1, 2017, 00:00

  • Utilization and Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Predictive Molecular Biomarker (BMX) Tests

    Oct 1, 2017, 00:00

  • Impact of Spironolactone on Das-28 in Naive Rheumatoid Arthritis Patients

    Oct 1, 2017, 00:00

  • Haemorrhoidal Artery Ligation Procedure For The Treatment of Symptomatic Grade II–III Heamorrhoids- A Trial-Based And Long-Term Model-Based Economic Evaluation

    Oct 1, 2017, 00:00

  • The Impact Of Systemic Juvenile Idiopathic Arthritis (SJIA) On A Caregiver’s Productivity And The Child’s Schooling

    Oct 1, 2017, 00:00

  • 2017 Black Box Amnog Rebates- What Is Driving The Rebates?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting

    Oct 1, 2017, 00:00

  • Utility Values Across Lines of Therapy in Immuno-Oncology Treatments- An Example from Advanced Melanoma

    Oct 1, 2017, 00:00

  • Fractional Polynomial Modelling In Network Meta-Analyses Of Cancer Immunotherapies In Advanced Non-Small Cell Lung Cancer (NSCLC)

    Oct 1, 2017, 00:00

  • Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) In Patients With Type 2 Diabetes Mellitus In Slovenia

    Oct 1, 2017, 00:00

  • Comparison of Catheter Ablation Versus Medical Treatment for Paroxysmal Atrial Fibrillation- Healthcare Utilization and Costs Analysis (Preliminary Results)

    Oct 1, 2017, 00:00

  • Costs of Major Complications of Type 2 Diabetes- A Systematic Review

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Oral Glycopyrronium Bromide (Sialanar™) For The Symptomatic Treatment of Severe Sialorrhoea (DROOLING) In The UK Setting

    Oct 1, 2017, 00:00

  • The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • New Drugs Approval In Italy- Analysis Of The Applied Negotiation Conditions 2015-2017

    Oct 1, 2017, 00:00

  • Modelling The Burden of Cardiovascular Disease In Colombia And The Impact of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • The Use of The Eortc Item Library To Supplement Eortc Quality of Life Instruments

    Oct 1, 2017, 00:00

  • Review Of The Reimbursement Environment For Advanced Therapeutic Medicinal Products (AtmpS) In The Uk

    Oct 1, 2017, 00:00

  • Patient Characteristics, Skeletal Related Events (SRE) And Renal Impairment (RI) In Patients With Multiple Myeloma (MM)- A Patient Chart Audit In EU5

    Oct 1, 2017, 00:00

  • Zoster Vaccine Effectiveness Against Incident Herpes Zoster and Post-Herpetic Neuralgia In Elderly In The UK

    Oct 1, 2017, 00:00

  • The Relationship Of Predicted Benefits In Life Expectancy And Quality Adjusted Life Expectancy For Improved Glucose Control In Type 2 Diabetes Simulation Modeling

    Oct 1, 2017, 00:00

  • Market Access of Advanced Therapy Medicinal Product (ATMP) In Europe- Lessons Learnt And Key Considerations for Future Success

    Oct 1, 2017, 00:00

  • Patient and Caregiver Burden in Congenital Adrenal Hyperplasia (CAH) in Children- Results of a Structured Literature Review

    Oct 1, 2017, 00:00

  • Competencies Of Formal Carers Regarding Basic Clinical And Soft Skills In The Provision Of Outpatient Services And Patients’ Perspective- The Two Sides Of The Same Coin

    Oct 1, 2017, 00:00

  • Secukinumab Vs Adalimumab for the Treatment of Psoriasic Arthritis- a Cost Per Responder Analysis at 48 Weeks from a Peruvian Perspective for Public and Private Health Schemes

    Oct 1, 2017, 00:00

  • An Economic Model To Support Decisions on The Adoption of A Live Vaccine To Aid in The Control of Salmonid Rickettsial Septicaemia (Srs) In Farmed Atlantic Salmon in Chile

    Oct 1, 2017, 00:00

  • Economic Burden of Burn Injuries Treated With An Enzymatic Debriding Agent In Spain

    Oct 1, 2017, 00:00

  • Costos de la Fibrilación Auricular en Colombia

    Oct 1, 2017, 00:00

  • Difference Between Annual National Health Statistics And 1-Complete-Year Medical Use In Cost-Estimation

    Oct 1, 2017, 00:00

  • Innovative Contracting- Use Of Complex Managed Entry Agreements

    Oct 1, 2017, 00:00

  • Use of New Therapies and Hospital Admission Near the End of Life in Castration Resistant Prostate Cancer (CRPC) in the Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

    Oct 1, 2017, 00:00

  • Economic Evaluation of Subcutaneous Methotrexate For Long-Term Treatment of Moderate-To-Severe Psoriasis In The United Kingdom

    Oct 1, 2017, 00:00

  • Mobile Cardiac Monitorization Is A Cost-Effective Tool For The Diagnosis And Management Of Atrial Fibrillation Compared To Holter- A Cost Effectiveness Study In Turkey

    Oct 1, 2017, 00:00

  • Unmet Healthcare Needs Due To Financial Reasons In Times Of Austerity

    Oct 1, 2017, 00:00

  • Effects Of Availability Of Essential Medicines List On Sellected Domains Of Pharmacy Services In A National Health Insurance Scheme (NHIS) Accredited Pharmacy Of A University Teaching Hospital In Nigeria; An Intervention Study

    Oct 1, 2017, 00:00

  • An Updated Review Of The Health Economic Burden Of Varicella In Latin America And The Caribbean

    Oct 1, 2017, 00:00

  • Infection Prevention In Heart Surgery In Germany- An Economic Analysis

    Oct 1, 2017, 00:00

  • The Association Between Multimorbidity, Socioeconomic Factors, And Multimorbidity-Related Excess Healthcare Use - Results From The 2014 National Health Interview Survey

    Oct 1, 2017, 00:00

  • A Comparison Of The Appraisals By The English National Institute For Health And Care Excellence (NICE) For Two Therapies For Relapsed Or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL)- Idelalisib+Rituximab (IR) And Ibrutinib

    Oct 1, 2017, 00:00

  • Older Adults’ Views On Incorporating Life Expectancy In Screening Choices – Results From A National Survey Using A Discrete-Choice Experiment

    Oct 1, 2017, 00:00

  • The FDA Approval of Eteplirsen – Necessary Flexibility or a Worrying Precedent?

    Oct 1, 2017, 00:00

  • Difficulties In Vaccine Introduction In A Large-Area Country- Meningococcal Vaccination In Russia

    Oct 1, 2017, 00:00

  • Cost Effectiveness Evaluation of Transradial Versus Transfemoral Access For Emergent Percutaneous Coronary Intervention In Patients With St Elevation Myocardial Infarction

    Oct 1, 2017, 00:00

  • Real World Evidence (RWE) on Long-Term Persistence of Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) in Australia

    Oct 1, 2017, 00:00

  • Budget Impact Analysis for Daclizumab Beta In Relapsing Remitting Multiple Sclerosis In Italy

    Oct 1, 2017, 00:00

  • Systematic Literature Review Of Economic Evaluations And Healthcare Resource Utilisation Studies In The Treatment Of Clostridium Difficile Infection

    Oct 1, 2017, 00:00

  • Adhrence To Routine Medical Screening Among Healthcare Professionals

    Oct 1, 2017, 00:00

  • Detrimental Impact of Toxicity on Quality of Life In Hepatocellular Carcinoma Patients Treated with Lenvatinibor Sorafenib

    Oct 1, 2017, 00:00

  • 20th Euro - FDS Financial Disclosure Statements

    Oct 1, 2017, 00:00

  • Qualitative Evaluation of Healthcare Provider Trust (And Mistrust) Among Patients with Symptomatic Peripheral Artery Disease

    Oct 1, 2017, 00:00

  • Measuring Changes In Patterns of Tobacco Product Use Over Time- Transition Probability Approaches

    Oct 1, 2017, 00:00

  • Budget Impact of The Inclusion of Oxycodone In The Brazilian Public Healthcare Setting For The Treatment of Cancer Pain

    Oct 1, 2017, 00:00

  • Pharmacological Adherence to Clinical Guidelines in Acute Coronary Syndrome in Hospitals

    Oct 1, 2017, 00:00

  • Cost Consequence Analysis of Immune-Enhancing Nutritional Formula in Patients with Digestive Cancer Surgery

    Oct 1, 2017, 00:00

  • Societal Cost Patterns By Spine Surgical Outcome Groups And Patients Treated With Spinal Cord Stimulation Following Spine Surgery

    Oct 1, 2017, 00:00

  • Landscape of Malignant Melanoma- The Impact of Upcoming Therapies

    Oct 1, 2017, 00:00

  • Societal Preferences For Funding Orphan Drugs In The UK- A Person Trade Off Study

    Oct 1, 2017, 00:00

  • Why Do ‘True’ Orphan Medicines Have Such A Low Acceptance Rate When Assessed By The SMC?

    Oct 1, 2017, 00:00

  • Evaluation of Health Care Reform Impact on Cancer Patients` Access To Medicine- A Pilot-Center Experience in Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Clinical and Economic History of The Oncological Patient At The End of Life

    Oct 1, 2017, 00:00

  • Estudio De Costo Efectividad Del Factor De Coagulación Recombinante VIII Unido A Proteina Fc Para El Tratamiento De La Hemofilia A En Chile

    Oct 1, 2017, 00:00

  • A Systematic Review of The Health-Related Quality of Life and Costs in Diffuse Large B-Cell Lymphoma

    Oct 1, 2017, 00:00

  • Regulatory Requirements for Non-Interventional Studies Collecting Patient Preferences and Experiences In France, Germany and The UK

    Oct 1, 2017, 00:00

  • Early Acess But Then What? The Uk Early Access To Medicines Scheme Three Year Report Card

    Oct 1, 2017, 00:00

  • Economic Effectiveness Of The Attune® Knee System - Analysis Of Real World Hospital Length Of Stay And Incidence Of Early Complications

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of The Use of Daclatasvir + Asunaprevir In The Treatment of Patients With Chronic Hepatitis C in Peru

    Oct 1, 2017, 00:00

  • Use of Disease Risk Score In The Evaluation of Effectiveness For Purposes of HTA

    Oct 1, 2017, 00:00

  • The Effectiveness and Cost-Effectiveness of Tobacco Control Mass Media Campaigns In Scotland

    Oct 1, 2017, 00:00

  • Predicting EQ-5D Index Scores From Promis Profile 29 In The United Kingdom, France, And Germany

    Oct 1, 2017, 00:00

  • Drug Utilization and Pharmacological Costs of Intravitreal Injected Antivegfs in Maculopathies in San Raffaele Hospital

    Oct 1, 2017, 00:00

  • A Real Word Treatment Patterns and Trends In Painful Diabetic Neuropathy and Postherpatic Neuralgia

    Oct 1, 2017, 00:00

  • Opioid Use Outcomes Among Female Breast Cancer Patients Using Adjuvant Endocrine Therapy Regimens

    Oct 1, 2017, 00:00

  • A Critical Quality Appraisal Of Studies Estimating The Cost Of Radiotherapy

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Mexico And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Análise De Custo Efetividade Da Toxina Onabotulínica A No Tratamento Preventivo Da Migrânea Crônica

    Oct 1, 2017, 00:00

  • Pharmacoeconomics of Certolizumab Pegol- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • The Association Between Multimorbidity And Subjective Health Status- Mediating Effect Of Activities Of Daily Livings

    Oct 1, 2017, 00:00

  • Consumer Comments in Health Technology Assessment in Australia- How Common and Influential Are They?

    Oct 1, 2017, 00:00

  • Early Response To Certolizumab Pegol In Rheumatoid Arthritis Predicts Outcome- Data From A Prospective Observational Study

    Oct 1, 2017, 00:00

  • Assessment of Isoniazid Prophylaxis Therapy Initiation Appropriateness, Adverse Drug Reaction and Adherence Among Hiv Patients In University of Gondar Referral Hospital, Northwest Ethiopia

    Oct 1, 2017, 00:00

  • Evaluation Of An Attitudes Toward Medical Errors Scale In Pharmacy And Healthcare Professional Students

    Oct 1, 2017, 00:00

  • Trend Analysis of Listing And Budget Impact For Orphan Drugs In Korea

    Oct 1, 2017, 00:00

  • The Cost of Tiotropium 5MCG + Olodaterol 5MCG In The Management Of Copd In Greece

    Oct 1, 2017, 00:00

  • The Disease Burden of Heart Failure in Portugal

    Oct 1, 2017, 00:00

  • Qualitative Research Methods For Collecting, Analyzing, And Presenting Patient-Reported Data On Noticeable And Important Change In Disease-Related Signs And Symptoms

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Deep Vein Thrombosis In Europe – Mortality And Health Related Quality Of Life

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns of PCSK9 Inhibitors Among Patients with Dyslipidemia in Germany, Spain, and United Kingdom

    Oct 1, 2017, 00:00

  • Clinical Inertia in Type 2 Diabetes Mellitus- Time in Poor Glycaemic Control Until Treatment Intensification in Patients on DPP-4I And/Or SGLT-2I Treatment

    Oct 1, 2017, 00:00

  • Development Of An Specific Evaluation Framework For Orphan Drugs Based On Multi-Criteria Decision Analysis (MCDA) For Health Care Decision Making In Catalonia

    Oct 1, 2017, 00:00

  • A Systematic Literature Review Of The Measurement Properties Of Generic Utility Instruments In East And Southeast Asia

    Oct 1, 2017, 00:00

  • Selecting Software Packages For Conducting Cost-Effectiveness Modelling In Health Care

    Oct 1, 2017, 00:00

  • Systematic Review on Clinical Outcomes of Ultrasonic Technology For Patients Undergoing Gyn Oncology Procedures

    Oct 1, 2017, 00:00

  • Prevalence and Antimicrobial Sensitivity of Salmonella from Fecal and Milk Samples of Lactating Cows, Debre-Zeit, Ethiopia

    Oct 1, 2017, 00:00

  • Stigmatisation Level Towards Mental Illness Patients Among Malaysian Urban and Rural Communities

    Oct 1, 2017, 00:00

  • Health-Related Quality Of Life And Rates Of Emergency Room Visits And Hospitalization In Patients With Al Amyloidosis- A Prospective Analysis

    Oct 1, 2017, 00:00

  • Health Insurance Perspective and Collective Perspective- The Differences In The Collection and Valuation of Cost Data In France

    Oct 1, 2017, 00:00

  • Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016

    Oct 1, 2017, 00:00

  • Determinantes De La Calidad De Vida Relacionada Con La Salud En Pacientes Con VIH/SIDA EN UNA Aseguradora EN Salud EN Colombia

    Oct 1, 2017, 00:00

  • Treatment for Cervix Uteri Cancer- Cost-Effectiveness Analysis in A Developing Country Context

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients With Chronic Phase- Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • Increasing Clinical Data Quality Through Interactive Data Visualization

    Oct 1, 2017, 00:00

  • NATIONAL POLICY ON HEALTH TECHNOLOGY MANAGEMENT- A CASE STUDY OF THE NATIONAL COMMITTEE FOR TECHNOLOGY INCORPORATION, BRAZIL (CONITEC)

    Oct 1, 2017, 00:00

  • Value Of Information Analysis Using Generalized Additive Model Regression- A Case Study In Heart Failure Disease Management

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Deep Brain Stimulation For The Treatment Of Parkinson’s Disease Patients In The Italian Setting

    Oct 1, 2017, 00:00

  • El Impacto Económico De La Comorbilidad En Un Sistema De Salud Privado En México

    Oct 1, 2017, 00:00

  • Generics Policies- A Systematic Review Of Their Effectiveness

    Oct 1, 2017, 00:00

  • EVidence Synthesis For Health Technology Assessment With Limited Studies

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Paliperidone Palmitate 3-Monthly for The Treatment of Schizophrenia In Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Empagliflozin In The Treatment Of T2d With Previous Cardiovascular Disease In Italy

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Trastuzumab Emtanzine in Patients with Metastatic Breast Cancer and Central Nervous System Metastases

    Oct 1, 2017, 00:00

  • Optimal Interval of Endoscopic Screening Based on Stage Distribution of Detected Gastric Cancer

    Oct 1, 2017, 00:00

  • Review Of Real-World Evidence To Assess The Burden Of Illness Of Mantle Cell Lymphoma

    Oct 1, 2017, 00:00

  • Interim Results of A Multi-Country Survey to Evaluate Productivity Loss and Indirect Costs after Cardiovascular Events in Europe

    Oct 1, 2017, 00:00

  • Disease Burden Mapping In Rare Diseases- An Example of Hypophosphatasia

    Oct 1, 2017, 00:00

  • Reviewing The Effectiveness of Uk Drug Horizon Scanning Efforts The Production of Nice Commentary Along Therapeutic Specialties

    Oct 1, 2017, 00:00

  • The Patient-Reported Apnea Questionnaire (PRAQ)- A Prom Optimized For Use On Both Individual Patient And Aggregate Level

    Oct 1, 2017, 00:00

  • Iso-Osmolar Contrast Media and Adverse Renal and Cardiac Events After Percutaneous Cardiovascular Intervention

    Oct 1, 2017, 00:00

  • Economic Burden Of Household For Treating Severe Pneumonia Among Under Five Children In Bangladesh

    Oct 1, 2017, 00:00

  • The Analysis Of Final And Surrogate Effectiveness Criteria Used In Health Economic Studies Of Drugs Submitted Into The Reimbursement In Russia In 2016

    Oct 1, 2017, 00:00

  • The Implications of Brexit on The UK Nhs and The UK Pharmaceutical Industry

    Oct 1, 2017, 00:00

  • Budget-Impact-Analysis of Iron Treatment using Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in Austria

    Oct 1, 2017, 00:00

  • The Effectiveness And Cost-Effectiveness Of Different Methods Of Recruiting Patients To A Pain Study

    Oct 1, 2017, 00:00

  • Family Caregiving in Dementia and its Impact on Quality of Life and Economic Burden in Japan – Web-Based Survey

    Oct 1, 2017, 00:00

  • Impact of Low Adherence On Cost-Effectiveness Of The Biological Treatment of Psoriasis (PSO) And Psoriatic Arthritis (PSA) In Slovenia

    Oct 1, 2017, 00:00

  • Pro Labeling in Products Approved by the European Medicines Agency (EMA) for Narcolepsy

    Oct 1, 2017, 00:00

  • Engaging Patients In The Development and Validation of Patient-Reported Outcome (PRO) Measures As Partners, Not Just Participants

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Tacrolimus As Primary Immunosuppression For Lung Transplant Recipients In The Czech Republic

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib Versus Erlotinib for The Treatment of Squamous Non-Small Cell Lung Cancer in France After A First-Line Platinium Based Therapy

    Oct 1, 2017, 00:00

  • Hearth Failure (HF) In Apulia Region - Italy (Local Health Unit Barletta – Andria – Trani)- Analysis Of The Therapeutic Pathways And Related Healthcare Consumption

    Oct 1, 2017, 00:00

  • How Do Nice Evidence Review Groups Perceive Single Technology Appraisals Presenting Limited Evidence of Comparative Treatment Efficacy?

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Tavi In Inoperable And High Risk Patients In France

    Oct 1, 2017, 00:00

  • I-O Optimise- Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology

    Oct 1, 2017, 00:00

  • Calibration Approach Impact on Health and Cost-Effectiveness Outcomes in a Decision Analytic Framework

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Omalizumab For The Treatment of Severe Allergic Ashtma In Korea

    Oct 1, 2017, 00:00

  • Heart Failure Management- Impact Of A New Health-Care Organisation On Readmissions And Costs

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Brazil

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib and Erlotinib as Second-Line Treatments for Advanced Squamous Cell Carcinoma of The Lung in China

    Oct 1, 2017, 00:00

  • Health Care Consumption And HRQOL In Severe Asthma In Sweden

    Oct 1, 2017, 00:00

  • Comparing The Effect of Progressive Relaxation And Perineal Strenghtening Interval Exercises Among Women With Primaer Dysmenorrhoea To Reduce Menstrual Cramps

    Oct 1, 2017, 00:00

  • The Budget Impact of Introducing Demineralised Bone Matrix Combined with Local Bone to Replace Currently Available Treatments for Lumbar Spinal Fusion Procedures in Spain

    Oct 1, 2017, 00:00

  • Patient Characteristics And Reasons for Biologic Monotherapy In Eu5 Markets In Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Mimicking Real Life Decision-Making in Health- Allowing Respondents Time-To-Think in a Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Cost-Savings Due to The Withdrawing of Biological Therapy for Treatment of Rheumathoid Artritis in A Specialized Center in Colombia

    Oct 1, 2017, 00:00

  • Assessing Methodologies For Health State Utilities In Paediatric Indications For Cost-Utility Analyses- Review Of Nice Technology Appraisals For Paediatric Indications

    Oct 1, 2017, 00:00

  • Medication Related Quality of Life Among Ethiopian Elderly Patients with Polypharmacy- The Case of North Gondar Zone

    Oct 1, 2017, 00:00

  • A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Incidence and Prevalence of Epilepsy in Germany

    Oct 1, 2017, 00:00

  • A Dynamic Decision Analysis Process For Evaluating Pandemic Influenza Intervention Strategies

    Oct 1, 2017, 00:00

  • Polypharmacy And Interactions - What Is A Pharmacist Role?

    Oct 1, 2017, 00:00

  • Developing and Piloting A Value Framework and a Tool to Inform the “Evidence-to-Decision Making” Process

    Oct 1, 2017, 00:00

  • Patient Characteristics and Treatment Patterns in Chronic Heart Failure- Results from a Multinational Real-World Cross Sectional Survey

    Oct 1, 2017, 00:00

  • Osteopathic Manipulative Therapy In Patients With Headache- Systematic Literature Review

    Oct 1, 2017, 00:00

  • Estimating Population Trends In Colorectal Cancer Stratified By Stage, Line of Therapy, And High Microsatellite Instability In The United States From 2017 To 2021

    Oct 1, 2017, 00:00

  • USO De Los Índices De Shannon En La Evaluación Del Poder Discriminante Del EQ-5D Y EL EQ-5D-5L En UNA Muestra De Pacientes Con VIH/SIDA En Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole in Private and Public Brazilian Hospitals

    Oct 1, 2017, 00:00

  • Adapting Pharmacoeconomics To Shape Efficient Health Systems En Route To Uhc - A Conceptual Framework

    Oct 1, 2017, 00:00

  • Quality of Life In Patients With Lyme Disease In Slovak Republic

    Oct 1, 2017, 00:00

  • Análisis De Variabilidad En Los Precios De Servicios En Salud Para Colombia

    Oct 1, 2017, 00:00

  • Regional Variations In Appraisal And Uptake Of New Treatments For Ultra Rare Diseases In The UK- A Case Study Of Ataluren For Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Pcv13 Vs Ppsv23 For The Immunization of Adults Over 65 Years with Low or Moderate Risk of Pneumococcal Infection

    Oct 1, 2017, 00:00

  • Use of Antipsychotics And The Risk of Colorectal Cancer- A Case-Control Study Using Data From The Linked Netherlands Cancer Registry And Pharmo Database Network Population

    Oct 1, 2017, 00:00

  • Implementation Of A Societal Cost-Effective Model Of A Swiss Canton School Vaccination Campaign Through A Hospital Pharmacy Logistics Platform

    Oct 1, 2017, 00:00

  • The Effect Of Nsaids On Myocardial, Vascular And Renal Risk Categories-Systematic Review Of Randomized Controlled Trial And Observational Studies

    Oct 1, 2017, 00:00

  • O Indicative Budget Impact Of Posaconazole Versus Itraconazole In Invasive Fungal Infection Prophylaxis In Adult Patients With Aml/Mds

    Oct 1, 2017, 00:00

  • Potential Savings Achieved Through Switching COPD Patients from ICS-Containing Regimens to LAMA-LABA- A Dutch Perspective

    Oct 1, 2017, 00:00

  • The Patient-Reported Disease Burden In Adults With Atopic Dermatitis- A Cross-Sectional Study In Canada and Europe

    Oct 1, 2017, 00:00

  • Hepatoprotective Effect Of Herbal Remedy With Anti-Tuberculosis Treatment

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Sorafenib Versus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma from Health Care System Perspective in Egypt

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Two Long-Acting Muscarinic Antagonists For Copd Treatment In Spain- Umeclidinium VS. Tiotropium (HO-17-18472)

    Oct 1, 2017, 00:00

  • The Evolution of Nice Medtech Innovation Briefings And Their Associated Technologies

    Oct 1, 2017, 00:00

  • The Development Of Acute And Chronic Inpatient Bed Capacities In Neurological, Neurosurgical And Psychiatric Professions Between 2002 And 2016 In Hungary

    Oct 1, 2017, 00:00

  • Assessment of Marketed and In-Development Products for Alzheimer’s Disease- What are the Strategic Value Drivers?

    Oct 1, 2017, 00:00

  • Influence of Peer Pressure Mechanism on Quality and Costs of Healthcare, on Examples of Israel, France and USA

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan In The Treatment Of Chronic Heart Failure With Reduced Ejection Fraction In Turkey

    Oct 1, 2017, 00:00

  • Assessing The Robustness Of Network Meta-Analysis Of Atypical Antipsychotics In The Presence Of Heterogeneity

    Oct 1, 2017, 00:00

  • Real-World Treatment Patterns in Stage IV Non-Squamous Non-Small Cell Lung Cancer in Argentina

    Oct 1, 2017, 00:00

  • Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Modeling Techniques for Fitting Healthcare Resource Use Costs Derived From Patient Reported Counts of Hospital, ER, And PCP Visits

    Oct 1, 2017, 00:00

  • Development And Psychometric Evaluation Of An Owner-Completed Measure Of Feline Health And Quality Of Life

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Selexipag For The Treatment Of Pulmonary Arterial Hypertension (PAH) In Greece

    Oct 1, 2017, 00:00

  • The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Neonatal Screening For Congenital Hypothyroidism

    Oct 1, 2017, 00:00

  • Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?

    Oct 1, 2017, 00:00

  • Glycemic Control of Adult Type 2 Diabetes Mellitus Patients In The Netherlands- A Cross-Sectional Real World Database Study

    Oct 1, 2017, 00:00

  • A Validation Study of The Rank-Preserving Structural Failure Time Model- Confidence Intervals, Unique, Multiple and Erroneous Solutions

    Oct 1, 2017, 00:00

  • Factors Associated with an Adherence with Antiepileptic Drugs in Children Treated in Pediatric Practices in Germany

    Oct 1, 2017, 00:00

  • Assessing The Utilization Of Diabetic Non-Small Cell Lung Cancer Patients Compared To Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Comparison of Early Scientific Advice Processes In UK, France And Germany (HTA ONLY)- Tips And Tricks

    Oct 1, 2017, 00:00

  • Pink October in the Social Media- Are We Still (MIS)Guiding the Public?

    Oct 1, 2017, 00:00

  • A Retrospective Database Analysis of Treatment Pathways And Estimated Costs of Treatment In Metastatic Colorectal Carcinoma (MCRC) In Germany

    Oct 1, 2017, 00:00

  • Identifying The Primary Outcome For A Randomised Controlled Trial In Rheumatoid Arthritis- The Role of A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Conceptual Model and Instrument Review in Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Impact of Disease Activity Measures and Patient Characteristics on Health Utilities in RMS

    Oct 1, 2017, 00:00

  • The Difference Between Regulatory And Market Access Decisions On Treatment Availability For New Drugs In Six Common Cancers Across Australia, Canada, And Europe

    Oct 1, 2017, 00:00

  • Terms Requiring Multiple Translations Or A Descriptive Translation In The Target Language And Vice Versa

    Oct 1, 2017, 00:00

  • The Implications of Vaccine Characteristics and Private-Sector Vaccination on Varicella; A Model-Based Analysis for Mexico

    Oct 1, 2017, 00:00

  • Impact of Ocrelizumab Vs. Interferon Beta-1a In Delaying The Deterioration Of Patients' Daily Functions and Associated Costs In Relapsing-Remitting Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Factors Associated With Sustained Smoking After Type 2 Diabetes Diagnosis In Korean Men

    Oct 1, 2017, 00:00

  • Tofacitinib in Adult Patients with Active Rheumatoid Arthritis- Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Treatment Patterns for RA Patients in Italian Real Practice

    Oct 1, 2017, 00:00

  • The Most Common Occupational Illnesses Of Medical- And Sports Masseurs

    Oct 1, 2017, 00:00

  • Access To Medicines- Developing An Indicator To Assess The Impact of Public Policies

    Oct 1, 2017, 00:00

  • Pharmacoepidemiology of Lateral Amiotrophic Sclerosis in the Republic of Belarus

    Oct 1, 2017, 00:00

  • Evaluation Of Health-Related Quality Of Life Among Malaysian Non Dialysis Dependent Chronic Kidney Disease Patients

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis (CEA) of Nivolumab in 2nd Line Non-Small Cell Lung Cancer (NSCLC) with Non-Squamous Histology (NSQ) Using A Mixed Comparator of Docetaxel and Pemetrexed in An Australian Setting

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Ivabradine In The Treatment of Patients With Chronic Heart Failure In Iran

    Oct 1, 2017, 00:00

  • Why Do People Participate In Health-Related Preference Studies? A Discrete-Choice Experiment

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Using Temocillin, A Narrow-Spectrum Antibiotic, As An Alternative To Broad-Spectrum Carbapenems

    Oct 1, 2017, 00:00

  • Bisphosphonates for Osteoporosis Treatment- A Cost-Effectiveness Analysis in Vietnamese Woman

    Oct 1, 2017, 00:00

  • Estimating Life Years And Quality-Adjusted Life Years In Heavily Treatment-Experienced (HTE) Patients

    Oct 1, 2017, 00:00

  • Pricing Regulation For Generics In Gree The Case Of Atorvastatin

    Oct 1, 2017, 00:00

  • The Italian Answer To Prep Topic- Evidence From A Multi-Centre HTA Study

    Oct 1, 2017, 00:00

  • Association Of Multiple Chronic Conditions With Health-Related Quality Of Life And Physical Functioning

    Oct 1, 2017, 00:00

  • Health Technology Assessment In Singapore- Shining A Light In The Darkness

    Oct 1, 2017, 00:00

  • Investigation Of Drug Therapy Problems In Type 2 Diabetes Outpatients With Comorbid Hypertension In A Tertiary Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Does the Distance to the Nearest Pharmacy Affect Medication Adherence Rates Among Elderly Patients with Diabetes?

    Oct 1, 2017, 00:00

  • Relapsing-Remitting Multiple Sclerosis Patients On Dimethyl Fumarate Reported Less Physical And Psychological Disease Impact In The Real World Compared With Patients On Platform Therapies

    Oct 1, 2017, 00:00

  • Self-Perceived Health in Latin America- Results from 2007-2008 Gallup World Poll

    Oct 1, 2017, 00:00

  • Clinical Characteristics and Outcome of The Influenza A (H1N1) Patients Admitted to the Tertiary Level Hospital, Peshawar

    Oct 1, 2017, 00:00

  • Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany- A Population-Based Modelling Study

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis (CUA) of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in the Brazilian Early Breast Cancer Patients

    Oct 1, 2017, 00:00

  • Misclassification of Diabetes Type I in German Claims Data

    Oct 1, 2017, 00:00

  • Does The Presence of An Orphan Drug Polcy Affect HTA Recommendations For Oncologic Orphan Drugs?

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis Of Transcatheter Aortic Valve Implantation In France

    Oct 1, 2017, 00:00

  • “Appraising the appraisers”- Do National Health Technology Assessment Agencies (NICE, GBA/IQWIG) Follow Their Official Evaluation Criteria?

    Oct 1, 2017, 00:00

  • Spatial Dynamics Of Psychiatric Disease Hospitalized Patients - Rehospitalization Simulation Focussing On Diabetes Comorbidity And Regional Health Services In Three European Regions Over The Next Decades

    Oct 1, 2017, 00:00

  • Analysis of Effectiveness Criteria In Pharmacoeconomic Studies of Antimicrobial Therapeutic Agents Proposed for Inclusion In The Essential Drug List (RUSSIA) In 2014-2016

    Oct 1, 2017, 00:00

  • Mapping the Modified Ashworth Scale and Physician’s Global Assessment to Preference-Based Health Utilities in Adults with Lower Limb Spasticity

    Oct 1, 2017, 00:00

  • Estimation of Indirect Costs of The Children Viral Acute Intestinal Infections Therapy in Ukraine

    Oct 1, 2017, 00:00

  • Cost Consequence of Introducing Paliperidone Palmitate 3-Monthly For The Maintenance Treatment of Schizophrenia In The English National Health Service (NHS)

    Oct 1, 2017, 00:00

  • Report of Low Density Lipoprotein (LDL) Levels in Patients Diagnosed Whit Hipertension, Diabetes Mellitus and Chronic Kidney Disease in Colombian Population

    Oct 1, 2017, 00:00

  • Specificities of Cancer Immunotherapy – Challenges From Market Access Perspective

    Oct 1, 2017, 00:00

  • Reevaluating A 10 Year Cost-Effectiveness Analysis (CEA) Of The Diabetes Prevention Program Outcomes Study (DPP/DPPOS)- Clarifying The Previous Confusion

    Oct 1, 2017, 00:00

  • The Study On Expression of Ap-1 Signaling Pathway and Polymorphisms Of Sep15 and Trxr-2 Genes In Kashin-Beck Disease

    Oct 1, 2017, 00:00

  • Using Convergent Mixed Methods To Evaluate Treatment Risks and Benefits In Rare Disease- An Example From A Phase Ii Registration Trial In Metastatic Merkel Cell Carcinoma

    Oct 1, 2017, 00:00

  • The Potential Value Of Multiparametric Magnetic Resonance Imaging In Active Surveillance Of Men With Low-Risk Prostate Cancer- A Cost-Effectiveness Modeling Study

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Screening For Severe Combined Immunodeficiency (SCID) In The UK NHS Newborn Bloodspot Screening Programme

    Oct 1, 2017, 00:00

  • Single Armed Observational Data To Closing The Gap In Otherwise Disconnected Evidence Networks

    Oct 1, 2017, 00:00

  • Economic Burden of Immune Thrombocytopenia (ITP) In Patients Receiving Eltrombopag (EPAG) And Romiplostim (ROMI)- Real World Evidence From 26 US Institutions

    Oct 1, 2017, 00:00

  • Delayed Biologic Switching Among Ankylosing Spondylitis (As) Patients May Result in Poor Health- Related Quality of Life- Results From A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • The Relationship of Quality of Life and Complete Psoriasis Clearance Over Time – Analyses From Brodalumab Trial Datasets

    Oct 1, 2017, 00:00

  • Will Prioritization of Vaccine Introduction Lead to a Higher Return of Investment? The Case of Colombia

    Oct 1, 2017, 00:00

  • Clinical And Cost Impact of A Novel Non-Invasive Approach For The Treatment of Cervical Dysplasia From A US Payer Perspective

    Oct 1, 2017, 00:00

  • Cost-Benefit Analysis of A Smoking Cessation Program Funded By The Spanish National System In Pre-Operative Patients

    Oct 1, 2017, 00:00

  • Costo-Efectividad Del Tratamiento De La Artritis Reumatoide (Ar) Temprana- Una Revisión Sistemática

    Oct 1, 2017, 00:00

  • Denied Oncology Treatment Claims- How Much Do They Cost and How Can we Prevent Resource Waste?

    Oct 1, 2017, 00:00

  • Challenges In Demonstrating Disease-Modifying Effects- Evidence-Based Testing Of A Novel Statistical Approach In Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Identifying Attributes of Cancer Treatments- What Do Stakeholders Consider Important?

    Oct 1, 2017, 00:00

  • Cost Impact of A Novel Prophylactic Treatment For Haemophilia A Patients With Inhibitors In The UK

    Oct 1, 2017, 00:00

  • Effects of Low Salt Diet on Gene Expression in Dog Heart

    Oct 1, 2017, 00:00

  • Title- Modelling The Effect of Syphilis Screening At The Entry Point in Chilean Prisons

    Oct 1, 2017, 00:00

  • Health Related Quality OF Life Standards in Patients with Parkinson

    Oct 1, 2017, 00:00

  • Hospital Resource Use in Metastatic Castration Resistant Prostate Cancer (MCRPC) in National University Hospitals in Japan

    Oct 1, 2017, 00:00

  • The Implementation Of Robotic-Assisted Surgery For Endometrial Cancer In The United States Lead To An Improvement Of Overall 30-Day Surgical Outcomes Without Increasing Costs- Is Technology Finally Allowing The Diffusion Of Minimally Invasi ...

    Oct 1, 2017, 00:00

  • IS TRANSTHEORETICAL MODEL’S STAGES OF CHANGE A GOOD PREDICTOR OF MEDICATION ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES?

    Oct 1, 2017, 00:00

  • A Review of Clinical Outcome Assessment Labeling in Europe and in the United States (2013-2016)

    Oct 1, 2017, 00:00

  • Economic Evaluation of Dasatinib Compared To Nilotinib as Second Line Treatment of Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • Short-Term Direct And Indirect Cost Burden of Cardiovascular Events In Patients With A History of Atherosclerotic Cardiovascular Disease In The US

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Physical Activity Promotion Intervention For People With Disabilities- A Markov Model Approach

    Oct 1, 2017, 00:00

  • Risk Sharing Agreements As Payment Mechanisms- A Comprehensive And Communicable Practical Approach For Stakeholders

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76 (current)
  • 77
  • 78
  • 79
  • 80
  • »